在儿童群体中指导药物诱导测试以检测ibuprofen过敏症:I3A风险分层工具的开发

Florian Stehlin1, Connor Prosty2, Angela Mulé2

  • 1Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Center (MUHC), McGill University, Montreal, QC, Canada; Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland; The Research Institute of the McGill University Health Centre, McGill University Health Centre (MUHC), McGill University, Montreal, QC, Canada.

概括

一个新的临床风险分层工具,I3A评分,有助于识别不太可能对ibuprofen挑战做出反应的儿童. 这种工具有助于安全指导药物诱导测试 (DPT) 怀疑ibuprofen过敏.